COVID-19与肺炎住院后糖尿病发病率的比较:一项队列研究
研究将2020年4月1日至8月31日英格兰因COVID-19和/或肺炎住院者与全国糖尿病审计数据链接,追踪出院后至2021年3月31日的新发糖尿病,并与2017、2018、2019年同期因肺炎住院队列比较,采用泊松回归计算校正发病率。结果显示COVID-19住院后糖尿病发病率与各对照队列无显著差异,数据不支持COVID-19对糖尿病发病率有明确影响。
要点
- 2020年单纯COVID-19无肺炎出院者糖尿病发病率为16.4/1000人年(95%CI 12.8-20.7)。
- 2020年COVID-19合并肺炎者发病率为19.0/1000人年(95%CI 13.8-25.6),2020年单纯肺炎者为16.6/1000人年(95%CI 13.3-20.4)。
- 上述发病率与2017、2018、2019年肺炎住院后发病率无显著差异。
核心结论
- 与包括同期肺炎住院者在内的多个对照队列相比,数据不支持COVID-19对糖尿病发病率有明确影响。
研究设计与样本
- 研究为队列研究,纳入2020年4月1日至8月31日在英格兰因COVID-19和/或肺炎住院者,并与全国糖尿病审计数据链接,识别出院后至2021年3月31日的新发糖尿病。
- 对照队列为2017、2018、2019年同期因肺炎住院者,分别随访至2018年3月31日、2019年3月31日、2020年3月31日。
- 采用泊松回归模型计算校正糖尿病发病率。
主要发现
- 以2020年因COVID-19无肺炎出院者为标准人群,糖尿病发病率为16.4/1000人年(95%CI 12.8-20.7)。
- 校正年龄、性别、族裔和贫困程度后,2020年因COVID-19合并肺炎住院者发病率为19.0/1000人年(95%CI 13.8-25.6),2020年因肺炎无COVID-19住院者为16.6/1000人年(95%CI 13.3-20.4)。
- 2019、2018、2017年因肺炎住院后发病率分别为13.7/1000人年(95%CI 10.8-17.3)、13.8/1000人年(95%CI 10.9-17.4)、14.2/1000人年(95%CI 10.9-18.3)。
- 上述发病率与2020年各队列相比无显著差异。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The incidence of diabetes may be elevated following coronavirus disease 2019 (COVID-19), but it is unclear whether this is specific to severe acute respiratory syndrome coronavirus 2 infection, associated with shared risk factors for severe COVID-19 and diabetes, and/or a generic risk following illness. RESEARCH DESIGN AND METHODS: People admitted to the hospital for COVID-19 and/or pneumonia between 1 April 2020 and 31 August 2020 in England were linked with the National Diabetes Audit to identify incident diabetes after discharge up to 31 March 2021. Comparator cohorts admitted with pneumonia over the same dates in 2017, 2018, and 2019 were followed until 31 March 2018, 31 March 2019, and 31 March 2020, respectively. Poisson regression models were used to calculate adjusted diabetes incidence rates. RESULTS: Using the cohort of people discharged from the hospital following a diagnosis of COVID-19 without pneumonia in 2020 as the standard population (incidence rate 16.4 [95% CI 12.8-20.7] per 1,000 person-years), adjusting for age, sex, ethnicity, and deprivation, gave incidence rates of 19.0 (95% CI 13.8-25.6) and 16.6 (95% CI 13.3-20.4) per 1,000 person-years for those admitted for COVID-19 with pneumonia and pneumonia without COVID-19, respectively, in 2020. These rates are not significantly different from those found after hospital admission for pneumonia in 2019, 2018, and 2017, at 13.7 (95% CI 10.8-17.3), 13.8 (95% CI 10.9-17.4), and 14.2 (95% CI 10.9-18.3) per 1,000 person-years, respectively. CONCLUSIONS: Our data do not support a clear impact of COVID-19 on the incidence of diabetes compared with risks in several comparator groups, including contemporaneously assessed risks in people hospitalized with pneumonia.
引用
- Holman N, Barron E, Young B, et al. Comparative Incidence of Diabetes Following Hospital Admission for COVID-19 and Pneumonia: A Cohort Study. Diabetes Care. 2023. PMID: 36657086. doi:10.2337/dc22-0670
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。